Strategic Collaborations Quiver Bioscience has established partnerships with Boston Children's Hospital and Angelini Pharma, and has worked with QurAlis and the Dup15q Alliance. These collaborations, along with ongoing NIH funding support, signal a receptive environment for co-development, data licensing, and joint CNS programs. This presents a direct opportunity to pitch data-driven discovery services, platform licensing, or targeted collaboration programs to pharma and academic partners.

AI Driven Platform Quiver's Genomic Positioning System GPS combines single-cell imaging, multi-omics, and AI/ML to generate information-rich neuronal insights. This unique capability can be productized as a licensing model for CNS target discovery, as a data analytics service for partner-led programs, or as a co-development engine for drug programs in neurology. BD teams should explore pilot collaborations to access GPS-derived targets and models.

CNS Focused Programs The company's current focus includes Nav1.7 ASO therapy for chronic neuropathic pain and collaborations around erythromelalgia and small fiber neuropathy. This creates a ready-made entry point for pharma and biotech partners seeking pain and rare neuropathy programs, with opportunities for co-discovery, preclinical validation in patient-derived neurons, and ASO development support.

Growth Readiness As a small but growing organization with a leadership change and a multi-million revenue footprint, Quiver is positioned to scale with external collaborations. Potential sales angles include contract research services around single-cell and multi-omics analyses, data licensing for GPS outputs, and development partnerships that accelerate lead programs into the clinic.

Funded Validation NIH UG3 funding and high-profile academic and industry partnerships validate the science and readiness for collaboration. This reduces perceived risk for potential partners and provides a compelling frame for joint grant-enabled programs, co-development deals, and long-term partnerships in brain health and neurology.